FAP and cancer: Baseline FAP concentrations were significantly lower in cancer patients (median 91 ng/mL, 25th-75th percentiles 72–123 ng/mL) compared to healthy controls (median 118 ng/mL, 25th-75th percentiles 104–140 ng/mL, P = 0.0002).